Literature DB >> 28457063

Prognostic Factors in Differentiated Thyroid Cancer Revisited.

Eran Glikson1, Eran Alon1,2, Lev Bedrin1, Yoav P Talmi1,2.   

Abstract

BACKGROUND: More than 90% of all thyroid cancers are differentiated thyroid carcinomas (DTC) with a 10 year survival rate greater than 90%. The commonly used risk stratification systems for DTC include: European Organization for Research and Treatment of Cancer (EORTC), AGES (Age, histologic Grade, Extent of tumor, Size), AMES (Metastasis) and MACIS (Completeness of resection, local Invasion). Other systems are also utilized. Several new factors that may be involved in DTC risk stratification have emerged in recent studies, with other "traditional" factors being challenged.
OBJECTIVES: To present recent updates in the literature on new potential prognostic factors for DTC.
METHODS: We conducted a literature review and analysis of publications regarding DTC prognostic factors or risk stratification published in the last 10 years.
RESULTS: Several new factors with potential prognostic implications for DTC were noted, including family history, lymph node involvement parameters, positive PET-CT findings, multifocal disease, thyroglobulin level and several molecular markers including BRAF. Increasing age is associated with poorer outcome in DTC; however, recent studies suggest that the cutoff point of 45 years may be contested. Furthermore, several studies have shown contradictory results regarding male gender as a negative prognostic factor, thus questioning its prognostic significance.
CONCLUSIONS: A number of new factors with potential prognostic implications for DTC have emerged and should be addressed. However, their role and possible inclusion in new staging systems has yet to be determined.

Entities:  

Mesh:

Year:  2017        PMID: 28457063

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  10 in total

1.  Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-up.

Authors:  R Michael Tuttle; Ali S Alzahrani
Journal:  J Clin Endocrinol Metab       Date:  2019-03-15       Impact factor: 5.958

Review 2.  Prognostic and predictive value of nuclear imaging in endocrine oncology.

Authors:  Giorgio Treglia; Bernard Goichot; Luca Giovanella; Elif Hindié; Abhishek Jha; Karel Pacak; David Taïeb; Thomas Walter; Alessio Imperiale
Journal:  Endocrine       Date:  2019-11-16       Impact factor: 3.633

3.  Differentiated Thyroid Cancer: How Do Current Practice Guidelines Affect Management?

Authors:  Patrick W Owens; Terri P McVeigh; Eoin J Fahey; Marcia Bell; Denis S Quill; Michael J Kerin; Aoife J Lowery
Journal:  Eur Thyroid J       Date:  2018-09-28

4.  Pan-metastatic cancer analysis of prognostic factors and a prognosis-based metastatic cancer classification system.

Authors:  Chao Zhang; Guijun Xu; Yao Xu; Haixiao Wu; Xu Guo; Min Mao; Vladimir P Baklaushev; Vladimir P Chekhonin; Karl Peltzer; Ye Bai; Guowen Wang; Wenjuan Ma; Xin Wang
Journal:  Aging (Albany NY)       Date:  2020-08-27       Impact factor: 5.682

5.  Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis.

Authors:  Youwen Zhu; Kun Liu; Kailing Wang; Libo Peng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

6.  Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?

Authors:  James J Figge; William E Gooding; David L Steward; Linwah Yip; Rebecca S Sippel; Samantha Peiling Yang; Randall P Scheri; Jennifer A Sipos; Susan J Mandel; Sarah E Mayson; Kenneth D Burman; Jessica M Folek; Bryan R Haugen; Julie A Sosa; Rajeev Parameswaran; Wee Boon Tan; Yuri E Nikiforov; Sally E Carty
Journal:  Thyroid       Date:  2021-09-01       Impact factor: 6.568

7.  Advanced thyroid carcinomas: neural network analysis of ultrasonographic characteristics.

Authors:  Michael Cordes; Theresa Ida Götz; Elmar Wolfgang Lang; Stephan Coerper; Torsten Kuwert; Christian Schmidkonz
Journal:  Thyroid Res       Date:  2021-06-29

8.  Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis.

Authors:  Thaís Gomes de Melo; Ligia Vera Montali da Assumpção; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2018-08-27       Impact factor: 3.257

9.  The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer.

Authors:  Xiaofei Wang; Jingqiang Zhu; Zhihui Li; Tao Wei
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

10.  Synergistic effects of histologic subtype, T-stage, and M-stage in the prognosis of differentiated thyroid cancer: a retrospective observational study.

Authors:  Ling Zhou; Shipei Wang; Sichao Chen; Yihui Huang; Di Hu; Wei Wei; Chao Zhang; Min Wang; Wei Zhou; Wen Zeng; Zeming Liu; Liang Guo
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.